Home >> Research Area >>Proteases/Proteasome>>Gamma Secretase>> YO-01027 (Dibenzazepine, DBZ)

YO-01027 (Dibenzazepine, DBZ)

γ-secretase inhibitor CAS# 209984-56-5

YO-01027 (Dibenzazepine, DBZ)

Catalog No. BCC2100----Order now to get a substantial discount!

Product Name & Size Price Stock
YO-01027 (Dibenzazepine, DBZ): 5mg $115 In Stock
YO-01027 (Dibenzazepine, DBZ): 10mg Please Inquire In Stock
YO-01027 (Dibenzazepine, DBZ): 20mg Please Inquire Please Inquire
YO-01027 (Dibenzazepine, DBZ): 50mg Please Inquire Please Inquire
YO-01027 (Dibenzazepine, DBZ): 100mg Please Inquire Please Inquire
YO-01027 (Dibenzazepine, DBZ): 200mg Please Inquire Please Inquire
YO-01027 (Dibenzazepine, DBZ): 500mg Please Inquire Please Inquire
YO-01027 (Dibenzazepine, DBZ): 1000mg Please Inquire Please Inquire
Related Products

Quality Control of YO-01027 (Dibenzazepine, DBZ)

Number of papers citing our products

Chemical structure

YO-01027 (Dibenzazepine, DBZ)

3D structure

Chemical Properties of YO-01027 (Dibenzazepine, DBZ)

Cas No. 209984-56-5 SDF Download SDF
PubChem ID 11454028 Appearance Powder
Formula C26H23F2N3O3 M.Wt 463.48
Type of Compound N/A Storage Desiccate at -20°C
Synonyms Dibenzazepine; DBZ
Solubility DMSO : ≥ 33 mg/mL (71.20 mM)
H2O : < 0.1 mg/mL (insoluble)
*"≥" means soluble, but saturation unknown.
Chemical Name (2S)-2-[[2-(3,5-difluorophenyl)acetyl]amino]-N-[(7S)-5-methyl-6-oxo-7H-benzo[d][1]benzazepin-7-yl]propanamide
SMILES CC(C(=O)NC1C2=CC=CC=C2C3=CC=CC=C3N(C1=O)C)NC(=O)CC4=CC(=CC(=C4)F)F
Standard InChIKey QSHGISMANBKLQL-OWJWWREXSA-N
Standard InChI InChI=1S/C26H23F2N3O3/c1-15(29-23(32)13-16-11-17(27)14-18(28)12-16)25(33)30-24-21-9-4-3-7-19(21)20-8-5-6-10-22(20)31(2)26(24)34/h3-12,14-15,24H,13H2,1-2H3,(H,29,32)(H,30,33)/t15-,24-/m0/s1
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Biological Activity of YO-01027 (Dibenzazepine, DBZ)

DescriptionYO-01027 (Dibenzazepine, DBZ) is a dipeptidic inhibitor of γ-secretase with IC50 of 2.6 nM and 2.9 nM for APPL and Notch cleavage, respectively.
TargetsAPPLNotch    
IC502.6 nM2.9 nM    

YO-01027 (Dibenzazepine, DBZ) Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

YO-01027 (Dibenzazepine, DBZ) Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of YO-01027 (Dibenzazepine, DBZ)

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 2.1576 mL 10.788 mL 21.5759 mL 43.1518 mL 53.9398 mL
5 mM 0.4315 mL 2.1576 mL 4.3152 mL 8.6304 mL 10.788 mL
10 mM 0.2158 mL 1.0788 mL 2.1576 mL 4.3152 mL 5.394 mL
50 mM 0.0432 mL 0.2158 mL 0.4315 mL 0.863 mL 1.0788 mL
100 mM 0.0216 mL 0.1079 mL 0.2158 mL 0.4315 mL 0.5394 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University

Background on YO-01027 (Dibenzazepine, DBZ)

YO-01027, also known as dibenzazepine or DBZ, is a potent inhibitor of γ-secretase, a multisubunit aspartyl protease catalyzing the cleavage of numerous type I integral membrane proteins (such as amyloid precursor protein (APP) and Notch). YO-01027 also potently blocks amyloid precursor protein-like (APPL) and Notch cleavage, with estimated inhibition constant IC50 of 2.640.30 nM and 2.920.22 nM respectively, through interaction with the N-terminal fragment of Presenilin in a dose-response manner. Recent studies show that YO-01027-induced inhibition Notch signaling pathway leads to a rapid conversion of proliferative crypt cells into postmitotic cells and impairs MUC16 biosynthesis in a concentration-dependent manner in undifferentiated cells instead of postmiotic stratified cells at both preconfluent and confluent stages.

Reference

Linjie Xiong, Ashley M. Woodward, and Pablo Argueso. Notch signaling modulates MUC16 biosynthesis in an vitro model of human corneal and conjunctival epithelial cell differentiation. Invest. Ophthalmol. Vis. Sci. 2011, 52(8), 5641-5646

Casper Groth, W. Gregory Alvord, Octavio A. Quinones, and Mark E. Fortini. Pharmacological analysis of drosphila melanogaster γ-secretase with respect to differential proteolysis of Notch and APP. Mol. Pharmacol. 2010, 77(4), 567-574

Featured Products
New Products
 

Description

YO-01027 (Dibenzazepine;DBZ) is a potent γ-secretase inhibitor with IC50 values of 2.92 and 2.64 nM for Notch and APPL cleavage, respectively.

Keywords:

YO-01027 (Dibenzazepine, DBZ),209984-56-5,Dibenzazepine; DBZ,Natural Products,Gamma Secretase, buy YO-01027 (Dibenzazepine, DBZ) , YO-01027 (Dibenzazepine, DBZ) supplier , purchase YO-01027 (Dibenzazepine, DBZ) , YO-01027 (Dibenzazepine, DBZ) cost , YO-01027 (Dibenzazepine, DBZ) manufacturer , order YO-01027 (Dibenzazepine, DBZ) , high purity YO-01027 (Dibenzazepine, DBZ)

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: